Do medications for breast cancer affect my fertility?

Question

Hello doctor,

I am 37 years old and living with metastatic breast cancer. I was recently advised to take Lynparza (Olaparib) due to a BRCA mutation. I am worried about fatigue and anemia, as my hemoglobin is already 10.2.

What side effects should I expect from Lynparza at my age?
How soon do side effects usually start? Are they dose-related?
Will it affect fertility or cause any long-term damage?

I would like to continue working if possible, as balancing treatment with quality of life is very important to me. Knowing what is normal versus concerning would help reduce anxiety before starting treatment.

Kindly advise.

Answer 1

Hello,

Welcome to icliniq.com.

I read your query and understand your concerns.

It makes sense to feel anxious before starting treatment, especially while already managing metastatic breast cancer and trying to maintain day-to-day quality of life and the ability to work. Olaparib, commonly used for BRCA (breast cancer gene)-related cancer, has a fairly predictable side effect pattern, and many patients can continue working with adjustments and close monitoring.

The most common early side effects include fatigue, nausea, reduced appetite, and low blood counts, especially anemia, which is particularly important since the hemoglobin is already 10.2 grams per deciliter.

Changes in blood counts often appear within the first few weeks of treatment and are one of the main reasons doctors monitor laboratory tests closely at the beginning. Dose adjustments may be needed if side effects become significant, so yes, side effects can often be dose-related and may improve with dose reduction without reducing effectiveness.

Fatigue may start slowly and could result from both Olaparib and anemia. The oncology team may monitor this closely and recommend checking iron levels, blood transfusions in some cases, or dosage adjustments.

Concerning fertility, Olaparib could have an effect on ovaries and might cause fertility reduction and early onset of menopause in some patients. If the issue of future fertility is of importance for the patient, you should consult with the medical oncologists before or during the therapy.

There are rare side effects like bone marrow disorders, like myelodysplastic syndrome (MSD) or leukemia; however, they happen rarely and are being controlled by regular blood testing. Most patients do not experience sudden and irreversible complications, but with supportive care, along with dose adjustments, you can maintain a reasonable quality of life.

Treatment for metastatic breast cancer is highly individualized. Reporting symptoms early and discussing proactive symptom management or dose adjustments can make treatment more manageable and support daily functioning.

I hope this is clear, and if you have any questions at any time, please feel free to ask.

Thank you.